Commercial serologic assays accurately detect adult Helicobacter pylori infection. Their use in children remains controversial. An ELISA to detect H. pylori IgG in children was developed and compared with three commercial assays. ELISA standardization was done with sera from all ages and validation was done with another cohort of sera with known H. pylori status. Three commercial serologic assays were subsequently compared against this pediatric ELISA at independent sites, at which 142 pediatric serum samples from different countries were evaluated. The pediatric ELISA was 91.4% sensitive. Assay 3 demonstrated a sensitivity of 78%. Less sensitivity was observed for assay 1 (70%) and assay 2 (63%). Accuracy of commercial assays was greatly reduced when sera from developing countries and younger ages were evaluated. Results of serologic tests used to diagnose H. pylori should be interpreted with caution when evaluating children with abdominal pain. Accurate serologic assays in children may be more important for epidemiologic research than for clinical decision making.
Infection with Helicobacter pylori is strongly associated with to H. pylori antigens [11, 15, 16] . In addition, detection of H. pylori -specific antibodies should provide evidence of ongoing gastroduodenal inflammation and causes chronic-active and chronic-persistent gastritis in humans worldwide [1, 2] . H. pygastric infection since, in the absence of specific eradication therapy, spontaneous clearance is extremely uncommon. Comlori infection also causes ú90% of primary duodenal ulcers in infected patients [3, 4] . Several epidemiologic studies describe mercial assays are generally limited, however, by use of antigens that are sensitive and specific only for populations in an association between this bacterium and the development of gastric malignancies, particularly if the infection is acquired as which the assays were validated [17] . Therefore, these assays may not be as sensitive when applied to populations from a young child [5 -8] . Because the majority of H. pylori infections are acquired in childhood, rapid noninvasive methods for different countries or persons of different ethnic backgrounds. Furthermore, previous studies have shown that cutoff values detection could be advantageous for screening of children with recurrent abdominal pain for H. pylori [9, 10] .
used to distinguish H. pylori -positive and -negative patients may differ between children and adults [18] . Variability in the The accepted standard criteria for diagnosis of H. pylori require invasive, endoscopically obtained gastric tissue to demchild's versus the adult's host immune response to H. pylori infection (i.e., level of IgG antibodies) was the explanation onstrate the characteristic spiral-shaped organism by histologic staining or its enzyme activity by urease test (e.g., CLO test;
given for different cutoff values, thereby necessitating the need to standardize an assay in both age groups. Trimed Specialties, Overland Park, KS) or by culture [11 -14] . Noninvasive serologic assays provide acceptable sensitivity Therefore, we developed an ELISA for the detection of H. pylori -specific antibodies that was sensitive and specific, parand specificity for the detection of past or current adult H. pylori infection by the presence of antibodies, primarily IgG, ticularly for H. pylori -infected children, and then compared the accuracy of this ELISA with that of three commercial serologic assays against sera obtained from a cohort of children. States, Canada, and South Africa, which had been stored at 070ЊC. plemented with 10% fetal bovine serum (Sigma, St. Louis), 5
Gastritis: chronic, mg/mL trimethoprim, and 10 mg/mL vancomycin (Sigma). After chronic-active, active 29 (65) 11 (12) shaking at 90-100 rpm, at 37ЊC, antigen extraction and protein Antigen specificity. Cross-reactivity and specificity of H. pylori whole cell antigens were evaluated by examining 15 heterologous bacteria in a standard competitive inhibition assay [20, 25, Serum samples from Canada were provided by Philip M. Sherman 26]. Briefly, whole cell antigens or outer membrane proteins were (Hospital for Sick Children, Toronto) and those from Taiwan by obtained from heterologous bacterial species, as well as from comNicholas Banatvala (CDC, Atlanta). The validation cohort included mon pediatric intestinal pathogens. The bacterial species used for 54 adults and 149 children.
cross-reactivity determination were as follows: Helicobacter ciFor comparison of the three commercial assays with our ELISA, naedi, Helicobacter fennelliae, Helicobacter mustelae, Helicowe tested 142 sera that were obtained after the assay was developed bacter felis, Helicobacter nemestrinae, Helicobacter acinonyx, from symptomatic children undergoing diagnostic upper endosWollinella succinogenes, Aerobacter butzleri, Campylobacter jecopy in Canada, South Africa, Taiwan, and the United States. In juni, Campylobacter coli, Campylobacter fetus, Escherichia coli our study cohort, on the basis of either histopathologic identifica-O157:H7, Pseudomonas aeruginosa (mucoid), P. aeruginosa (nontion of organisms by Giemsa or Warthin-Starry stain, a positive mucoid), Burkordelia cepacia, and the controls: H. pylori (posirapid urease test (CLO) result, or positive culture, 42 children were tive) and PBS (negative). Before performing the ELISA, the known H. pylori -infected and 100 were uninfected. Patient characteristics H. pylori -positive and H. pylori -negative pediatric and adult conare shown in table 1. Relatively equal distributions of patients were trol patient sera (1:1000) were incubated for 2 h with each of the drawn from each geographic area to ensure adequate comparisons whole cell sonicates from the bacterial species listed in table 2, in between groups. Histopathologic characterization of gastric biopsy varying concentration (0.125-40 mg/mL) with shaking at room specimens was done independently by pathologists at the contributtemperature. This antigen-antibody complex was then added to the ing institutions. Grading of gastritis, ranging from mild to severe, solid-phase H. pylori antigens held at a constant (10 mg/mL), was done by using the modified Sydney criteria [12, 19] . For incubated at 37ЊC for 2 h at 150 rpm, and then left at 4ЊC overnight. ELISA standardization and validation as well as assay compari-
The secondary antibody (1:10,000), a polyclonal rabbit anti-human IgG, conjugated to horseradish peroxidase (Sigma), was added to sons, each serum specimen was analyzed without access to the range, the patient's serum was considered indeterminate. We eval- Assay 3 uated the mean OD for each control over the total number of Positive 11 0 assays for which the ELISA was used to determine the degree of Negative 3 15 variability between these control sera from one assay to the next.
This determination also allowed us to define the reproducibility of Commercial assay evaluation of pediatric sera. All patient Indeterminate 7 3 sera from the study cohort (n Å 142) were evaluated for anti-H. ucts). We also determined how our ELISA performed in the evaluation of H. pylori IgG antibodies in adult sera. The sera from 60 adult patients, all of whom had undergone diagnostic upper each well and incubated for 2 h at 37ЊC, with shaking at 150 rpm.
endoscopy, were evaluated in a blinded fashion with respect to For the purpose of this study, IgG antibodies alone were evaluated.
histologic diagnosis and H. pylori infection status. Our laboratory has previously reported the evaluation of IgM antiAssay 1 is a direct EIA for the detection of H. pylori -specific bodies in children, demonstrating an ability to detect specific IgM IgG antibodies, uses a urease-enriched preparation, and was valiantibodies in very young children but much more variability and dated against gastric biopsy. Assay 1 is carried out at a 1:20 less accuracy in its detection in older age groups [27] . dilution and demonstrates a sensitivity of 96%-100% and speciAdditional ELISA cross-reactivity was determined with sera ficity of 89%-94% in adults. Assay 2 is a semiquantitative reversefrom H. pylori -negative sick controls. These controls were chilflow immunochromatography assay to detect H. pylori -specific dren with documented clinical gastroenteritis, who were H. pyloriIgG antibodies, uses a solid-phase antigen of high molecular negative by endoscopically obtained biopsy and who had one of weight and cell-assorted proteins, and was previously validated the following enteric pathogens isolated from stool culture: E. against the 13 C urea breath test and gastric biopsy. Its past perforcoli O157:H7 or Campylobacter, Salmonella, or Shigella species. mance with adult sera demonstrated sensitivity of 93%-97% and Endoscopy had been done on these children by the treating gastrospecificity of 87.6%-95.1% in the evaluation of undiluted serum enterologist, based on clinical information deemed important specimens under described conditions. Cross-reactivity for assay enough for the patient to warrant undergoing invasive diagnostic 1 and 2 was determined against C. jejuni, C. fetus, E. coli, and H. studies. Cross-reactivity of sera from sick controls against the H. mustelae by a described method [26, 28] . Assay 3 was validated pylori antigens was determined using serial dilutions (undiluted to against the urea breath test; it has demonstrated cross-reactivity 1:64,000) while holding the solid-phase antigen and secondary similar to the other two commercial assays and uses patient serum antibody concentrations constant.
at a 1:100 dilution to yield sensitivity of 89%-98% and specificity Results variability when evaluating sera from the younger age groups (õ9 years; data not shown). Furthermore, our ELISA demonDevelopment of ELISA for detection of H. pylori IgG antistrated a sensitivity of 89% and specificity of 93% when we bodies in children. Whole cell antigens from a single clinical evaluated patient sera from different geographic origins. In H. pylori strain isolated from a 14-year-old girl with chroniccontrast, more variability was observed when comparing the active gastritis and multiple duodenal ulcers were the best of performance of the commercial assays in the evaluation of all solid-phase antigens evaluated. Using a method described children's sera from different geographic regions (table 3) . by Atherton et al.
[29], we demonstrated that this H. pylori
In contrast, all four serologic assays performed much more isolate contained the cytotoxin genes cagA and vacA and the consistently in the evaluation of adult sera. Sensitivity calculacorresponding proteins (data not shown). These antigens tions for all assays demonstrated a mean of ú94%, with varishowed no cross-reactivity when tested against 15 genetically ability of õ2.8% between individual assays. Similar findings and phenotypically related bacteria at concentrations from were also observed for the specificity of the assays in the 0.125 to 40 mg/mL. A negative control (PBS) showed no inhibievaluation of adult sera (94.6%), with a variability of 4% tion, whereas 100% inhibition was achieved by H. pylori proamong all four assays. teins (i.e., positive control). Antigen sensitivity was not increased by combining whole cell proteins from different H. Discussion pylori strains or by using purified outer membrane proteins (data not shown). Varying the concentration of the solid-phase
We developed a 96-well microtiter immunoassay with a high antigen demonstrated that a concentration of 10 mg/mL allowed degree of specificity and sensitivity in determining presence a distinct and complete separation between the true H. pyloriof H. pylori infection in children, irrespective of a patient's positive and H. pylori -negative subjects. The values detergeographic origin or the extent of gastroduodenal injury. The mined represent the means of the known serum specimens, whole cell antigens used in our ELISA had very limited crosseach being evaluated separately, and not a single pooled sera.
reactivity with an extensive array of heterologous, as well as Serial dilutions of individual patient sera demonstrated optimal genetically and phenotypically similar, bacterial species [11, sensitivity of the immunoassay at a patient serum dilution of 15, 30] . When compared to the three commercial assays used 1:1000 and a secondary antibody dilution of 1:10,000. Thus, for the independent evaluation of adult serum samples, our these parameters were then used for the routine testing of sera.
ELISA performed similarly. In contrast, our ELISA was far The ELISA clearly separated both pediatric and adult H. pysuperior to the three commercial assays in evaluating pediatric lori -infected patients from those uninfected at an OD value sera, particularly in terms of sensitivity and its positive and õ0.86 and ú1.32 (l Å 492 nm). The indeterminate range for negative predictive value. The sensitivity of our ELISA was an individual serum sample was thereby defined as OD between greater than that of all three commercial assays, whereas the 0.86 and 1.32 [18, 20] . For ú3650 samples now run with our specificities of the other three ELISAs were much closer to the ELISA, calculations for variability of the positive and negative specificity of our ELISA. controls run in each plate were made. OD for the positive In our ELISA development, an additional step was taken to control showed a variance of õ3% (2.5%) in all assays, with ensure a high degree of specificity of the selected solid-phase a mean OD of 1.935 { 0.206. OD for the negative control was antigens. Further determination of the cross-reactivity of our 0.365 { 0.243, with a variance of 3.6% in all assays.
ELISA was done by using sera from children who were infected Comparison of serologic assays. Our ELISA demonstrated with other enteric pathogens (Campylobacter, Salmonella, Shia 91.4% sensitivity and a 97.9% specificity in the evaluation gella species), yet not by H. pylori, as determined by diagnostic of 142 pediatric sera, with a negative predictive value of 96.9% endoscopic evaluation. To our knowledge, this type of crossand a positive predictive value of 94.1%. reactivity determination has not been done in the development Overall, the three commercial ELISAs demonstrated lower of most commercially available serologic assays, including sensitivities than the pediatric ELISA (tables 2 and 3). Assay those evaluated by us [26, 28, 30, 31] . The degree of cross-1 had a sensitivity of 70% and specificity of 97%, with a reactivity for the majority of the assays reported has been positive predictive value of 89% and a negative predictive routinely investigated by evaluating whole cell sonicates from value of 91%. Assay 2 had sensitivity and specificity of 62% other pathogens and detection of a reduction in H. pylori IgG and 96%, respectively, with a positive predictive value of 86% antibody binding to the EIA solid-phase antigen. We not only and a negative predictive value of 87%. Assay 3 demonstrated performed this step in determining specificity of our ELISA, better sensitivity (78%) than the other two commercial assays evaluating a broad range of genetically and phenotypically and a specificity of 100%, with positive and negative predictive similar bacteria, but also evaluated patient serum with antibodvalues of 100% and 83%, respectively. No significant variabilies to these bacteria to detect presence or absence of crossity was demonstrated by our ELISA when children were strareactivity with the ELISA solid-phase antigens. tified into age groups: 0 -4, 5 -9, 10 -14, and §15 years. How-
The differences we observed in test accuracy may be explained by antigenic variability in infecting H. pylori strains, ever, the commercial assays showed significantly more / 9d4c$$au25 06-29-98 17:03:18 jinfa UC: J Infect which results in variable host immune responses [32 -35] . This explanation for their decreased accuracy when evaluating pediatric patient sera from developing countries. variability in the immune response due to H. pylori strain differences may be particularly noticeable in children in whom the Noninvasive tests such as serology for the detection of H. pylori infection would be valuable diagnostic tools in the evaluainitial infection occurs, thereby resulting in inconsistent systemic immune responses. Alternatively, an explanation for the tion of a child with chronic abdominal pain. However, as the natural history of H. pylori infection and the host or environmendifferences in test accuracy may be variability in the child's (host) immune response due to duration of colonization or tal risk factors for infection still remain unclear, accurate serologic assays for children may have an even more important role overall bacterial load rather than H. pylori strain differences. Furthermore, we speculate that the significantly lower sensitivin population-based, case-control epidemiologic studies. Moreover, other assays for antibody detection in whole blood, urine, ity observed in the commercial assays may be due primarily to the lack of standardization and validation of these assays or saliva in the pediatric age group have merit but no proven use in the clinical arena. Additionally, urea breath testing may with serum samples from H. pylori -infected and -uninfected pediatric patients [18, 26, 28] . If the three commercial assays prove to have even more applicability as a diagnostic assay than does serology, particularly as a test for cure, but validation in had been standardized and validated and new cutoffs determined with characterized pediatric sera, we believe that these children still needs to be done [38] . Our ELISA clearly demonstrated a reproducible superiority in the detection of H. pylori assays might then become applicable in the appropriate circumstances. The question still remains as to the overall usefulness IgG antibodies in children with evidence of gastric mucosal disease and H. pylori infection on endoscopy. In addition, the of serology in clinical decision making and the evaluation of either adults or children in the workup of abdominal pain or IgG titers of H. pylori-infected children did not seem to vary significantly according to the severity of the mucosal inflammapeptic ulcer symptoms [36] .
Finally, we demonstrated that variability and differences in tion (data not shown). Further qualitative study of the use of an ELISA to predict severity of mucosal disease, particularly in sensitivity, specificity, and positive and negative predictive values between the commercial assays and our ELISA were altered children, in whom the infection appears to be acquired, thus representing an early stage in the disease evolution, seems warto some extent when patients were stratified by geographic region and by age. In particular, the commercial assays demonranted. Additional comparative studies of serology with other assays for detection of IgG antibodies in saliva and whole blood strated less sensitivity and specificity, as well as decreased positive and negative predictive value, when evaluating H. pyand urea breath testing in children need to be performed and substantially validated [38] . Also, studies that determine the lori -infected children living in developing countries (South Africa, Taiwan) than when evaluating children from industrialeffect of H. pylori strains (phenotype, genotype) on the immune response in both children and adults, and the modification of ized nations (United States, Canada). On the contrary, our ELISA performed comparably when results obtained for paserologic assays to correspond with the variable immune response, should be undertaken. In conclusion, we believe that tients from developed compared with developing countries were stratified. This variability was not observed when the there maybe a role for H. pylori screening serology when evaluating a child with recurrent abdominal pain. However, caution study cohort was stratified by ethnicity or race. This observation has been shown in previous studies that demonstrated that must be used when interpreting results of any serologic assay. One must determine that the diagnostic assay has been standardcommercial assays are not applicable for use in geographic locations different from those in which the particular assays ized and validated in the pediatric age group and in patients from the same geographic region, particularly if applied outside were developed, standardized, and validated [17, 32, 33, 37] . All three commercial assays were developed and evaluated the United States. Therefore, the use of serology in clinical decision making in children remains unclear. using sera obtained from United States -born adults, a possible
